
Ceftrivin TZ 250mg/31.25mg Injection
Marketer
Vintek Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Ceftrivin TZ 250mg/31.25mg Injection
Combiflox TZ Injection, containing 250mg/31.25mg of its active components, combats bacterial infections by inhibiting microbial growth. Administration must always be under a doctor's guidance; complete the prescribed course, even with symptom improvement, to ensure efficacy. Missed doses should be avoided. Potential side effects include gastrointestinal upset (nausea, vomiting, diarrhea, indigestion). Severe reactions, including allergic responses (rash, itching, swelling, respiratory distress), warrant immediate medical attention. Inform your physician of all current medications, especially if pregnant or breastfeeding, prior to commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if experiencing dizziness or somnolence. Rest, a balanced diet, and ample hydration are crucial for optimal recovery. Monitoring may include laboratory tests to assess treatment effectiveness.
Primary Ingredients of Ceftrivin TZ 250mg/31.25mg Injection
No text provided to rephrase.
Uses of Ceftrivin TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Ceftrivin TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Ceftrivin TZ 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Ceftrivin TZ 250mg/31.25mg Injection:
The medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Ceftrivin TZ 250mg/31.25mg Injection works:
Ceftriaxone and Tazobactam, combined as Ceftrivin TZ 250mg/31.25mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a crucial antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. The addition of Tazobactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby bolstering Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Ceftrivin TZ 250mg/31.25mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ceftrivin TZ 250mg/31.25mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nonetheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Ceftrivin TZ 250mg/31.25mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Ceftrivin TZ 250mg/31.25mg Injection could lead to drowsiness, blurred vision, or dizziness. Refrain from driving if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Data regarding Ceftrivin TZ 250mg/31.25mg Injection use in individuals with renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Ceftrivin TZ 250mg/31.25mg Injection to individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Ceftrivin TZ 250mg/31.25mg Injection dosage is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Ceftrivin TZ 250mg/31.25mg Injection :
Omitting a dose of Ceftrivin TZ 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Ceftrivin TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
